Middle East and Africa Point-of-Care (POC) Drug Abuse Testing Market

Middle East and Africa Point-of-Care (POC) Drug Abuse Testing Market

Middle East and Africa Point-of-Care (POC) drug abuse testing market is expected to reach USD 78.11 million by 2031 from USD 61.20 million in 2023, growing at a CAGR of 3.3% in the forecast period of 2024 to 2031.


Middle East and Africa Point-of-Care (POC) Drug Abuse Testing Market, By Drug Type (Amphetamines, Opiates, Cannabinoids, Cocaine, Barbiturates, Benzodiazepines, Methadone, Phencyclidine, Tricyclic Antidepressants, and Others), Products (Devices and Consumables and Accessories), Prescription (Over the Counter Testing and Prescription-Based Testing), Sample Type (Urine, Saliva, Blood, Hair, Breath, and Others), Testing Type (Random Testing, Post-Incident Testing, and Abstinence Testing), Application (Medical Screening, Workplace Screening, Law Enforcement and Criminal Justice, Pain Management, Substance Abuse Treatment and Rehabilitation, Parental or Home Drug Testing, Sports and Athletics Testing, Drug Screening in Schools and Educational Institutions, and Others), End User (Healthcare Facilities, Employers, Government Institutes, and Others), Distribution Channel (Direct Tender, Retails Sales, and Others), Countries (South Africa, Egypt, Saudi Arabia, U.A.E., Israel, Kuwait, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2031

Overview of Middle East and Africa Point-of-Care (POC) Drug Abuse Testing Market Dynamics:

Driver

• Rising incidence of drug abuse
Restrain

• Data security and privacy concerns

Opportunity

• Growing awareness and the campaign for drug testing
Market Players:

The key market players operating in the Middle East and Africa Point-of-Care (POC) Drug Abuse Testing Market are listed below:

• Abbott
• Agilent Technologies
• BD
• Bio-rad Laboratories inc.
• F.HOFFMAN-LA ROCHE LTD.
• MERCK KGAA, DARMSTADT, GERMANY
• BASF SE
• Quest Diagnostics
• SIEMENS HEALTHINEERS AG
• THERMO FISHER SCIENTIFIC INC.